The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma

被引：0
作者：
You Quan Li [1 ]
Ni Sann Khin [1 ]
Melvin LKChua [1 ,2 ]
机构：
[1] Division of Radiation Oncology,National Cancer Center
[2] Oncology Academic Clinical Program, Duke-NUS Medical School
来源：
Cancer Biology & Medicine | 2018年 / 01期
关键词：
NPC; Ig; EBV; The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma; VCA;
D O I：
暂无
中图分类号：
R739.63 [咽肿瘤];
学科分类号：
100214 ;
摘要：
<正>The detection of Epstein-Barr virus(EBV)in nasopharyngeal carcinoma(NPC)has evolved over the last40 years,transitioning from simple serological tests of latent viral infection to extremely sensitive measurements of the
引用
收藏
页码：1 / 5
页数：5
相关论文
共 10 条
[1]  
Carcinogenesis of nasopharyngeal carcinoma:an alternate hypothetical mechanism[J]. Sharon Shuxian Poh,Melvin Lee Kiang Chua,Joseph T.S.Wee.Chinese Journal of Cancer. 2016(01)
[2]  
Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma[J]. K.C.Allen Chan.Chinese Journal of Cancer. 2014(12)
[3]  
Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells[J]. Chi Man Tsang,Wen Deng,Yim Ling Yip,Mu-Sheng Zeng,Kwok Wai Lo,Sai Wah Tsao.Chinese Journal of Cancer. 2014(11)
[4]   Circulating Human Papillomavirus DNA as a Marker for Disease Extent and Recurrence Among Patients With Oropharyngeal Cancer [J].
Dahlstrom, Kristina R. ;
Li, Guojun ;
Hussey, Caroline S. ;
Vo, Jenny T. ;
Wei, Qingyi ;
Zhao, Chong ;
Sturgis, Erich M. .
CANCER, 2015, 121 (19) :3455-3464
[5]   Use of Human Papillomavirus 16 (HPV16) Cell Free DNA for Assessment of Response to Chemoradiation in HPV-Associated Oropharyngeal Cancer [J].
Higginson, D. S. ;
Scher, E. D. ;
Yarusi, B. ;
Chan, S. ;
Mitrani, L. ;
Thompson, C. ;
Cleary, C. R. ;
McBride, S. M. ;
Riaz, N. ;
Lee, N. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03) :S78-S79
[6]   Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China [J].
Ji, Ming-Fang ;
Huang, Qi-Hong ;
Yu, Xia ;
Liu, Zhiwei ;
Li, Xinghua ;
Zhang, Li-Fang ;
Wang, Panpan ;
Xie, Shang-Hang ;
Rao, Hui-Lan ;
Fang, Fang ;
Guo, Xiang ;
Liu, Qing ;
Hong, Ming-Huang ;
Ye, Weimin ;
Zeng, Yi-Xin ;
Cao, Su-Mei .
CANCER, 2014, 120 (09) :1353-1360
[7]  
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities[J] . Xueming Sun,Shengfa Su,Chunyan Chen,Fei Han,Chong Zhao,Weiwei Xiao,Xiaowu Deng,Shaomin Huang,Chengguang Lin,Taixiang Lu.Radiotherapy and Oncology . 2013
[8]   Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program [J].
Chan, K. C. Allen ;
Hung, Emily C. W. ;
Woo, John K. S. ;
Chan, Paul K. S. ;
Leung, Sing-Fai ;
Lai, Franco P. T. ;
Cheng, Anita S. M. ;
Yeung, Sze Wan ;
Chan, Yin Wah ;
Tsui, Teresa K. C. ;
Kwok, Jeffrey S. S. ;
King, Ann D. ;
Chan, Anthony T. C. ;
van Hasselt, Andrew C. ;
Lo, Y. M. Dennis .
CANCER, 2013, 119 (10) :1838-1844
[9]  
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations .2 Li YY,Chung GT,Lui VW,To KF,Ma BB,Chow C,et al. Nat Commun . 2017
[10]  
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma .2 Lo YM,Chan LY,Lo KW,et al. Cancer Research . 1999
1